Methicillin‐Resistant Staphylococcus aureus in French Hospitals: A 2‐Month Survey in 43 Hospitals, 1995

• Published in: Infection control and hospital epidemiology Vol. 20; no. 7; pp. 478 - 486
• Format: Journal Article
• Language: English
• Published: Thorofare, NJ The University of Chicago Press 01-07-1999; Slack; Cambridge University Press
• Subjects: Bacterial diseases; Biological and medical sciences; France; France - epidemiology; Hospital admissions; Hospital beds; Hospital units; Hospitals; Hospitals, Public; Hospitals, University; Human bacterial diseases; Humans; Incidence; Infection control; Infections; Infectious diseases; Medical sciences; Methicillin Resistance; Methicillin resistant staphylococcus aureus; Nursing; Nursing homes; Original Articles; Psychiatric hospitals; Public health; Staphylococcal Infections - epidemiology; Staphylococcal Infections - microbiology; Staphylococcal infections, streptococcal infections, pneumococcal infections; Staphylococcus; Staphylococcus aureus; Staphylococcus aureus - drug effects; Staphylococcus aureus - isolation & purification; France; Europe; Human; Nosocomial infection; Epidemiology; Incidence; Infection; Bacteriosis; Hospital ward; Bacteria; Micrococcales; Isolation; Micrococcaceae; Hospital; Transmission mode; Localization; Staphylococcal infection; Sanitary surveillance; Staphylococcus aureus
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1086/501656

To estimate the incidence of methicillin-resistant Staphylococcus aureus (MRSA) in patients hospitalized in French public hospitals.
A 2-month survey that included 163,573 patients and 140,114 admissions.
Forty-three public or public-affiliated hospitals throughout France, including 12 university-affiliated hospitals. Information was recorded on all patients having MRSA recovered from culture of any clinical sample.
The overall median incidence rate (per 1,000 admissions) of clinically detected MRSA was 5.9 (range, 1.8-15.8); median rates were similar in hospitals affiliated or not affiliated to universities (6.4 and 5.9, respectively). Smaller unaffiliated hospitals (<500 beds) had higher MRSA incidence rates (mean, 7.2) than larger (>500 beds) unaffiliated hospitals or university hospitals (mean, 6.7 and 6.1, respectively). The incidence density (per 1,000 patient-days) of MRSA was higher in intensive-care units [ICUs] 2.39/1,000) than in surgical (0.80/1,000) and medical (0.70/1,000) wards, respectively; comparable rates were recorded in rehabilitation units (0.67/1,000), whereas in long-term-stay units, the incidence density of MRSA was 0.27/1,000 patient-days. Of 958 MRSA isolates, 660 (69%) also were resistant to all aminoglycosides. In 411 (43%) of 958 patients, the MRSA isolate was considered imported (ie, first recovered within 72 hours of the patient's admission to the unit). More than one half (53%) of imported cases were transfer patients from other hospitals, and 17% originated from ICUs.
MRSA is extensive in French hospitals. All categories of hospitals are involved to a similar extent, and there is intense circulation of patients colonized or infected with MRSA between units and hospitals. Containment of MRSA would mandate increasing resources devoted to infection control, especially in smaller hospitals, and control programs should involve notification of carriers and screening of patients at risk of MRSA carriage on admission to detect carriers and to implement isolation precautions rapidly.